Clinically significant bleeding due to chemotherapy-induced thrombocytopenia occurs in <10% of patients with solid tumours. [7] However, thrombocytopenia-related costs can be substantial even in ...

The study population comprised 228 patients whose previous treatment with first-line chemotherapy or at ... therapy in patients with bortezomib-induced thrombocytopenia.

A brief overview of the pathophysiology, diagnosis, and treatment of heparin-induced thrombocytopenia (HIT) is discussed. Following any exposure to unfractionated heparin or low-molecular-weight ...